Besides tumor vascularization, STAT3 activity in TAMs seems to promote tumorigenesis and therapeutic resistance by nurturing a population of cancer cells with increased tumorigenic potential, known as cancer stem/initiating cells. This evidence concerns the gene STAT3 and neoplasm.